|
|
||||||||
Eur J Cardiothorac Surg 2007;32:209-214. doi:10.1016/j.ejcts.2007.04.036
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
a Department of Pediatric Thoracic and Cardiovascular Surgery, Congenital Cardiac Center (Deutsches Kinderherzzentrum), Sankt Augustin, Germany
b Department of Pediatric Cardiology, Congenital Cardiac Center (Deutsches Kinderherzzentrum), Sankt Augustin, Germany
c Department of Cardiac Intensive Care, Congenital Cardiac Center (Deutsches Kinderherzzentrum), Sankt Augustin, Germany
d Department of Anesthesiology and Critical Care Medicine, Congenital Cardiac Center (Deutsches Kinderherzzentrum), Sankt Augustin, Germany
Received 16 February 2007; received in revised form 25 April 2007; accepted 30 April 2007.
* Corresponding author. Address: Deutsches Kinderherzzentrum, Asklepios Klinik, Arnold-Janssen-Strasse, 29 53757 Sankt Augustin, Germany. Tel.: +49 2241 249601; fax: +49 2241 249602. (Email: n.sinzobahamvya{at}asklepios.com).
Objective: This study analyzes whether small-diameter Contegras behave in the same way as small-diameter homografts, when implanted for the first time in pulmonary position. Methods: Small-diameter conduits include 12 and 14 mm Contegras and 8–14 mm homografts. Graft dysfunction is defined as right ventricular outflow tract obstruction with peak echo-Doppler gradient > 40 mmHg, or grade III/IV graft regurgitation. Graft failure is defined as need for conduit replacement or need for catheter or surgical reintervention. Thirty-eight patients who received small Contegras (n = 25) and small homografts (n = 13) from October 2002 to end December 2006 were studied. The most frequent indication was pulmonary atresia and ventricular septal defect (n = 20; 10 associated with major aorto-pulmonary collateral arteries), followed by truncus arteriosus (n = 12). Most patients characteristics were comparable except that recipients of homografts were smaller (p for body area = 0.014). Survival, freedom from graft dysfunction, failure and explantation were estimated by the Kaplan–Meier method. The log-rank test was used to compare outcomes. Results: There were three early and four late deaths. No death was graft related. Survival was 80 ± 8.2% for patients with Contegras and 77 ± 11.7% for those with allografts: p = 0.82. Mean follow-up duration is 22 ± 16 months. Freedom from dysfunction for Contegra conduits decreased in the first 6 months and stabilized at 58 ± 11% from month 14. For homografts it decreased only 1 year after implantation, down to 35 ± 19.7% from month 31: p = 0.61. Freedom from Contegra failure diminished the first 16 months to level out at 57 ± 13%. No homograft failed the first 2 years. With a p-value of 0.14, homografts tended to fail less frequently. Five grafts were explanted. Freedom from explantation was similar (p = 0.98): 90 ± 6.7% for Contegras and 75 ± 21.6% for homografts at year 3. Conclusion: In the first 4 years after pulmonary implantation of small-diameter Contegras and homografts, the fate of both conduits was statistically similar, in spite of different behavior. As Contegra is off-the-shelf available, it constitutes a sound alternative to homograft for right ventricular outflow tract reconstruction in neonates and infants.
Key Words: Valved conduits Contegra Homograft Right ventricular outflow tract reconstruction
This article has been cited by other articles:
![]() |
O. Raisky, W. B. Ali, F. Bajolle, D. Marini, O. Metton, D. Bonnet, D. Sidi, and P. R. Vouhe Common arterial trunk repair: with conduit or without? Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 675 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ando and Y. Takahashi Ten-year experience with handmade trileaflet polytetrafluoroethylene valved conduit used for pulmonary reconstruction. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 124 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Park, W.-K. Jhang, J.-K. Ko, Y.-H. Kim, and T.-J. Yun Lecompte operation: Is it still a viable option for truncus arteriosus? J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1384 - 1386.e2. [Full Text] [PDF] |
||||
![]() |
C. D. Derby, J. Kolcz, S. Gidding, and C. Pizarro Outcomes following non-valved autologous reconstruction of the right ventricular outflow tract in neonates and infants Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 726 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sinzobahamvya, M. Boscheinen, H. C. Blaschczok, R. Kallenberg, J. Photiadis, C. Haun, V. Hraska, and B. Asfour Survival and reintervention after neonatal repair of truncus arteriosus with valved conduit Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 732 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Hickey, B. W. McCrindle, E. H. Blackstone, T. Yeh Jr., F. Pigula, D. Clarke, C. I. Tchervenkov, J. Hawkins, and the CHSS Pulmonary Conduit Working Group Jugular venous valved conduit (Contegra(R)) matches allograft performance in infant truncus arteriosus repair Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 890 - 898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |